PD-1 and PD-L1 antibodies in cancer: current status and future directions
Get full text
Journal Article
Book Review
Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
Weber, Jeffrey S, Kähler, Katharina C, Hauschild, Axel
Published in Journal of clinical oncology (20.07.2012)
Published in Journal of clinical oncology (20.07.2012)
Get full text
Journal Article
Toxicities of Immunotherapy for the Practitioner
Weber, Jeffrey S, Yang, James C, Atkins, Michael B, Disis, Mary L
Published in Journal of clinical oncology (20.06.2015)
Published in Journal of clinical oncology (20.06.2015)
Get full text
Journal Article
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Schadendorf, Dirk, Hodi, F Stephen, Robert, Caroline, Weber, Jeffrey S, Margolin, Kim, Hamid, Omid, Patt, Debra, Chen, Tai-Tsang, Berman, David M, Wolchok, Jedd D
Published in Journal of clinical oncology (10.06.2015)
Published in Journal of clinical oncology (10.06.2015)
Get full text
Journal Article
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
Rodig, Scott J, Gusenleitner, Daniel, Jackson, Donald G, Gjini, Evisa, Giobbie-Hurder, Anita, Jin, Chelsea, Chang, Han, Lovitch, Scott B, Horak, Christine, Weber, Jeffrey S, Weirather, Jason L, Wolchok, Jedd D, Postow, Michael A, Pavlick, Anna C, Chesney, Jason, Hodi, F Stephen
Published in Science translational medicine (18.07.2018)
Published in Science translational medicine (18.07.2018)
Get more information
Journal Article
Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma
Daud, Adil I, Wolchok, Jedd D, Robert, Caroline, Hwu, Wen-Jen, Weber, Jeffrey S, Ribas, Antoni, Hodi, F Stephen, Joshua, Anthony M, Kefford, Richard, Hersey, Peter, Joseph, Richard, Gangadhar, Tara C, Dronca, Roxana, Patnaik, Amita, Zarour, Hassane, Roach, Charlotte, Toland, Grant, Lunceford, Jared K, Li, Xiaoyun Nicole, Emancipator, Kenneth, Dolled-Filhart, Marisa, Kang, S Peter, Ebbinghaus, Scot, Hamid, Omid
Published in Journal of clinical oncology (01.12.2016)
Published in Journal of clinical oncology (01.12.2016)
Get full text
Journal Article
Ipilimumab and Its Toxicities: A Multidisciplinary Approach
Fecher, Leslie A., Agarwala, Sanjiv S., Hodi, F. Stephen, Weber, Jeffrey S.
Published in The oncologist (Dayton, Ohio) (01.06.2013)
Published in The oncologist (Dayton, Ohio) (01.06.2013)
Get full text
Journal Article
Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients
Peters, Brandilyn A, Wilson, Melissa, Moran, Una, Pavlick, Anna, Izsak, Allison, Wechter, Todd, Weber, Jeffrey S, Osman, Iman, Ahn, Jiyoung
Published in Genome medicine (09.10.2019)
Published in Genome medicine (09.10.2019)
Get full text
Journal Article
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Weber, Jeffrey S, Dr, D'Angelo, Sandra P, MD, Minor, David, MD, Hodi, F Stephen, MD, Gutzmer, Ralf, MD, Neyns, Bart, MD, Hoeller, Christoph, MD, Khushalani, Nikhil I, MD, Miller, Wilson H, MD, Lao, Christopher D, MD, Linette, Gerald P, MD, Thomas, Luc, MD, Lorigan, Paul, FRCP, Grossmann, Kenneth F, MD, Hassel, Jessica C, MD, Maio, Michele, MD, Sznol, Mario, MD, Ascierto, Paolo A, MD, Mohr, Peter, MD, Chmielowski, Bartosz, MD, Bryce, Alan, MD, Svane, Inge M, MD, Grob, Jean-Jacques, MD, Krackhardt, Angela M, MD, Horak, Christine, PhD, Lambert, Alexandre, PhD, Yang, Arvin S, MD, Larkin, James, FRCP
Published in The lancet oncology (01.04.2015)
Published in The lancet oncology (01.04.2015)
Get full text
Journal Article
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
WOLCHOK, Jedd D, HOOS, Axel, HUMPHREY, Rachel, STEPHEN HODI, F, O'DAY, Steven, WEBER, Jeffrey S, HAMID, Omid, LEBBE, Celeste, MAIO, Michele, BINDER, Michael, BOHNSACK, Oliver, NICHOL, Geoffrey
Published in Clinical cancer research (01.12.2009)
Published in Clinical cancer research (01.12.2009)
Get full text
Journal Article
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
Eggermont, Alexander M M, Prof, Chiarion-Sileni, Vanna, MD, Grob, Jean-Jacques, Prof, Dummer, Reinhard, Prof, Wolchok, Jedd D, MD, Schmidt, Henrik, MD, Hamid, Omid, MD, Robert, Caroline, Prof, Ascierto, Paolo A, Prof, Richards, Jon M, MD, Lebbé, Céleste, Prof, Ferraresi, Virginia, MD, Smylie, Michael, MD, Weber, Jeffrey S, MD, Maio, Michele, MD, Konto, Cyril, MD, Hoos, Axel, MD, de Pril, Veerle, MSc, Gurunath, Ravichandra Karra, MD, de Schaetzen, Gaetan, PhD, Suciu, Stefan, PhD, Testori, Alessandro, MD
Published in The lancet oncology (01.05.2015)
Published in The lancet oncology (01.05.2015)
Get full text
Journal Article
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
Robert, Caroline, Prof, Ribas, Antoni, Prof, Wolchok, Jedd D, Prof, Hodi, F Stephen, MD, Hamid, Omid, MD, Kefford, Richard, Prof, Weber, Jeffrey S, Prof, Joshua, Anthony M, PhD, Hwu, Wen-Jen, Prof, Gangadhar, Tara C, MD, Patnaik, Amita, MD, Dronca, Roxana, MD, Zarour, Hassane, Prof, Joseph, Richard W, MD, Boasberg, Peter, MD, Chmielowski, Bartosz, MD, Mateus, Christine, MD, Postow, Michael A, MD, Gergich, Kevin, MA, Elassaiss-Schaap, Jeroen, PhD, Li, Xiaoyun Nicole, PhD, Iannone, Robert, MD, Ebbinghaus, Scot W, MD, Kang, S Peter, MD, Daud, Adil, Prof
Published in The Lancet (British edition) (20.09.2014)
Published in The Lancet (British edition) (20.09.2014)
Get full text
Journal Article
Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma
WEBER, Jeffrey S, RAGINI REINEY KUDCHADKAR, KROEGER, Jodi, EYSMANS, Cabell, SARNAIK, Amod A, ANN CHEN, Y, BIN YU, GALLENSTEIN, Donna, HORAK, Christine E, INZUNZA, H. David, XIUHUA ZHAO, MARTINEZ, Alberto J, WENSHI WANG, GIBNEY, Geoffrey
Published in Journal of clinical oncology (01.12.2013)
Published in Journal of clinical oncology (01.12.2013)
Get full text
Journal Article
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
Sarnaik, Amod A, Hamid, Omid, Khushalani, Nikhil I, Lewis, Karl D, Medina, Theresa, Kluger, Harriet M, Thomas, Sajeve S, Domingo-Musibay, Evidio, Pavlick, Anna C, Whitman, Eric D, Martin-Algarra, Salvador, Corrie, Pippa, Curti, Brendan D, Oláh, Judit, Lutzky, Jose, Weber, Jeffrey S, Larkin, James M G, Shi, Wen, Takamura, Toshimi, Jagasia, Madan, Qin, Harry, Wu, Xiao, Chartier, Cecile, Graf Finckenstein, Friedrich, Fardis, Maria, Kirkwood, John M, Chesney, Jason A
Published in Journal of clinical oncology (20.08.2021)
Published in Journal of clinical oncology (20.08.2021)
Get full text
Journal Article
Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial
Weber, Jeffrey S, Prof, Gibney, Geoff, MD, Sullivan, Ryan J, MD, Sosman, Jeffrey A, Prof, Slingluff, Craig L, Prof, Lawrence, Donald P, MD, Logan, Theodore F, MD, Schuchter, Lynn M, Prof, Nair, Suresh, MD, Fecher, Leslie, MD, Buchbinder, Elizabeth I, MD, Berghorn, Elmer, BSN, Ruisi, Mary, MD, Kong, George, PhD, Jiang, Joel, PhD, Horak, Christine, PhD, Hodi, F Stephen, Dr
Published in The lancet oncology (01.07.2016)
Published in The lancet oncology (01.07.2016)
Get full text
Journal Article
Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
WEBER, Jeffrey S, O'DAY, Steven, URBA, Walter, POWDERLY, John, NICHOL, Geoff, YELLIN, Michael, SNIVELY, Jolie, HERSH, Evan
Published in Journal of clinical oncology (20.12.2008)
Published in Journal of clinical oncology (20.12.2008)
Get full text
Journal Article
Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
STEPHEN HODI, F, CORLESS, Christopher L, O'DAY, Steven J, KIM, Kevin B, LAWRENCE, Donald, FLAHERTY, Keith T, LUKE, Jason J, COLLICHIO, Frances A, ERNSTOFF, Marc S, HEINRICH, Michael C, BEADLING, Carol, ZUKOTYNSKI, Katherine A, GIOBBIE-HURDER, Anita, YAP, Jeffrey T, VAN DEN ABBEELE, Annick D, DEMETRI, George D, FISHER, David E, FLETCHER, Jonathan A, MEIJUN ZHU, MARINO-ENRIQUEZ, Adrian, FRIEDLANDER, Philip, GONZALEZ, Rene, WEBER, Jeffrey S, GAJEWSKI, Thomas F
Published in Journal of clinical oncology (10.09.2013)
Published in Journal of clinical oncology (10.09.2013)
Get full text
Journal Article
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
Wolchok, Jedd D., Hodi, F. Stephen, Weber, Jeffrey S., Allison, James P., Urba, Walter J., Robert, Caroline, O'Day, Steven J., Hoos, Axel, Humphrey, Rachel, Berman, David M., Lonberg, Nils, Korman, Alan J.
Published in Annals of the New York Academy of Sciences (01.07.2013)
Published in Annals of the New York Academy of Sciences (01.07.2013)
Get full text
Journal Article